31 studies found for:    " April 08, 2009":" May 08, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Unknown  Cognitive and Psychosocial Benefits of MISC Training for Ugandan Children
Conditions: HIV;   HIV Infections
Intervention: Behavioral: MISC training for primary caregivers
22 Completed Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy
Conditions: HIV;   Hyperlipidemia;   Hypertriglyceridemia;   HIV Infections
Intervention: Drug: raltegravir
23 Unknown  Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population
Conditions: Hepatitis C Virus;   HIV Infections;   Pregnancy
Intervention:
24 Completed
Has Results
A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.
Condition: HIV Infections
Interventions: Drug: Nevirapine Immediate Release (IR);   Drug: Nevirapine Extended Release (XR)
25 Active, not recruiting Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons
Conditions: HIV Infections;   Coronary Artery Disease;   Non-Alcoholic Fatty Liver Disease
Intervention:
26 Completed Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers
Condition: HIV Infections
Interventions: Biological: RotaTeq vaccine;   Biological: RotaTeq vaccine placebo
27 Unknown  Safety and Efficacy of GS-9350-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Condition: HIV-1 Infection
Interventions: Drug: 150 mg tablet GS- 9350;   Drug: ritonavir 100 mg capsule;   Drug: atazanavir 300 mg capsule;   Drug: emtricitabine/tenofovir DF 200/300 mg tablet;   Drug: ritonavir placebo;   Drug: GS-9350 placebo
28 Withdrawn Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women
Condition: HIV-1 Infections
Interventions: Drug: TDF/FTC Once-Daily + Raltegravir 400 mg Orally Twice-Daily;   Drug: TDF/FTC + Efavirenz (Atripla) Once-Daily
29 Completed
Has Results
Triomune Bioequivalence With Innovators
Condition: HIV/AIDS
Interventions: Drug: Triomune;   Drug: Zerit/Epivir/Viramune
30 Unknown  7-valent Pneumococcal Conjugated Vaccination
Condition: Invasive Pneumococcal Disease
Intervention: Biological: 7-valent pneumococcal conjugated vaccine
31 Completed A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019)
Condition: HIV-1 Infection
Interventions: Biological: V520;   Biological: Comparator: ALVAC-HIV vaccine

Show previous page of results Previous Page (1-20) Studies Shown (21-31) Next Page
Indicates status has not been verified in more than two years